Results 1 to 10 of about 2,896 (119)

Lysophospholipid receptors in neurodegeneration and neuroprotection [PDF]

open access: yesExploration of Neuroprotective Therapy
The central nervous system (CNS) is one of the most complex physiological systems, and treatment of CNS disorders represents an area of major medical need.
Eric Birgbauer
doaj   +2 more sources

Lysophospholipid receptors in vertebrate development, physiology, and pathology

open access: yesJournal of Lipid Research, 2009
Lysophospholipid (LP) research has experienced a period of renaissance with the discovery of the lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) receptors in the late 1990s.
Athanasia Skoura, Timothy Hla
doaj   +1 more source

Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding

open access: yesLipids in Health and Disease, 2021
Background Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that acts through its six cognate G protein-coupled receptors. As a family, lysophospholipids have already produced medicines (e.g., sphingosine 1-phosphate) as is being pursued for ...
Manisha Ray   +3 more
doaj   +1 more source

Advances in lysophosphatidic acid for bone remodeling [PDF]

open access: yesKouqiang yixue
Lysophosphatidic acid (LPA), a simple bioactive lysophospholipid widely dispersed in human body, has been reported to regulate the proliferation, chemotaxis and differentiation of multiple cells and further participate in various developmental and ...
ZHANG Qin, XIANG Lin, GONG Ping
doaj   +1 more source

Roles of polyunsaturated fatty acids, from mediators to membranes

open access: yesJournal of Lipid Research, 2020
PUFAs, such as AA and DHA, are recognized as important biomolecules, but understanding their precise roles and modes of action remains challenging. PUFAs are precursors for a plethora of signaling lipids, for which knowledge about synthetic pathways and ...
Takeshi Harayama, Takao Shimizu
doaj   +1 more source

Effects of a lysophosphatidic acid receptor 1 antagonist on hypertensive renal injury in Dahl-Iwai salt-sensitive rats

open access: yesJournal of Pharmacological Sciences, 2022
Lysophosphatidic acid (LPA) is a biologically active lysophospholipid, and acts on six types of LPA receptors (LPA1-LPA6). LPA-LPA1 signaling has been suggested as a therapeutic target for inflammatory and fibrotic disorders, including renal fibrosis.In ...
Takumi Naruse   +2 more
doaj   +1 more source

Novel lysophosphoplipid receptors: their structure and function

open access: yesJournal of Lipid Research, 2014
It is now accepted that lysophospholipids (LysoGPs) have a wide variety of functions as lipid mediators that are exerted through G protein-coupled receptors (GPCRs) specific to each lysophospholipid.
Kumiko Makide   +6 more
doaj   +1 more source

Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology

open access: yesBMC Neuroscience, 2008
Background Lysophospholipids regulate the morphology and growth of neurons, neural cell lines, and neural progenitors. A stable human neural progenitor cell line is not currently available in which to study the role of lysophospholipids in human neural ...
Callihan Phillip   +6 more
doaj   +1 more source

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development

open access: yesMediators of Inflammation, 2017
Lysophosphatidic acid (LPA) is a ubiquitous lysophospholipid and one of the main membrane-derived lipid signaling molecules. LPA acts as an autocrine/paracrine messenger through at least six G protein-coupled receptors (GPCRs), known as LPA1–6, to induce
Silvia Anahi Valdés-Rives   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy